S
HH2; PH2); Mutagenic (1; AMA; APA); Natriuretic (f; PH2); Nephrotoxic (1; AMA); Sweetener
(f; APA); Vasodilator (1; AMA; APA).
Indications (Stevia) — Bacteria (f; APA); Diabetes (1; APA; HHB); Hyperglycemia (1; AMA);
Hypertony (f; HH2); High Blood Pressure (1; AMA; APA; HH2; PH2); Hyperglycemia (1; APA;
PH2; SYN); Inflammation (1; HH2); Swelling (1; HH2); Syndrome X (1; SYN); Water Retention
(1; AMA; APA; PH2).
Dosages (Stevia) — 1–2 capsules StX (57 mg extract 85% steviosides) with beverage (NH).
Contraindications, Interactions, and Side Effects (Stevia) — Class 1 (AHP). No health hazards
known with proper use as a sweetener (PH2). AMA (Alternative Medicine Alert) suggests that
one byproduct of stevia metabolism may be mutagenic (APA); steviol, a metabolite of stevioside
“has been found to be highly mutagenic in several in vitro studies” (AMA 3:13). Insufficient
human data exist regarding safety in pregnancy and lactation. Hence, “pregnant and lactating
patients should avoid stevia” (AMA 3:13). Limited data suggest it may be a contraceptive (APA).
Stevioside is “about one hundred times sweeter than sucrose at a 10% concentration” (APA).
Liquid leaf extracts significantly decrease plasma glucose levels after overnight fasting in 16
healthy adults (APA).
ST. JOHN’S-WORT
(Hypericum perforatum L.) ++ (Raised from CRC)
Activities (St. John’s-Wort) — Analgesic (1; CAN; CRC; EFS); Anticancer (1; MAB);
Antibacterial (1; FAD; MAB; PH2; VVG); Antidepressant (2; APA; BGB; CRC; PH2; SHT;
WAM); Antidote (1; FNF; MAD); Antiedemic (1; CAN); Antiherpetic (1; MAB); Antiinflam-
matory (1; APA; FAD; PIP; PH2); Antineuralgic (f; BGB); Antiretroviral (1; APA; FAD);
Antiseptic (1; HHB; PH2); Antispasmodic (f; HHB); Antiulcerogenic (1; CAN); Antiviral (2;
APA; PH2; SKY; VVG); Anxiolytic (2; PH2; PNC); Aperitif (1; CAN); Astringent (f; CRC;
EFS; PNC); COMT Inhibitor (f; MAB); Cholagogue (f; CRC; EFS); Digestive (f; CRC; EFS);
Diuretic (f; BGB; DEP; EFS; VVG); Dopaminergic (1; MAB; PH2); Emmenagogue (f; DEM;